Mirum Pharmaceuticals, Inc.MIRMNASDAQ
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | -84.71% |
| Q3 2025 | 229.58% |
| Q2 2025 | 713.97% |
| Q1 2025 | 61.31% |
| Q4 2024 | -227.21% |
| Q3 2024 | 204.76% |
| Q2 2024 | -125.00% |
| Q1 2024 | 191.54% |
| Q4 2023 | 8.80% |
| Q3 2023 | -5.14% |
| Q2 2023 | 7.69% |
| Q1 2023 | 45.22% |
| Q4 2022 | -31.68% |
| Q3 2022 | -29.02% |
| Q2 2022 | 49.15% |
| Q1 2022 | -19.68% |
| Q4 2021 | 3.08% |
| Q3 2021 | 14.92% |
| Q2 2021 | -59.46% |
| Q1 2021 | 30.51% |
| Q4 2020 | -107.89% |
| Q3 2020 | -2.69% |
| Q2 2020 | 7.39% |
| Q1 2020 | -33.97% |
| Q4 2019 | 10.01% |
| Q3 2019 | -89.86% |
| Q2 2019 | -230.46% |
| Q1 2019 | -348.84% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |